CALLAVID
LIVE

Serial Number

79401819

Owner

Calla Lily Clinical Care Ltd

Attorney

Matthew Frisbee

Filing Date

Feb 9, 2024

Add to watchlist:

No watchlists yet
View on USPTO

CALLAVID Trademark

Serial Number: 79401819 • Registration: 8105548

CALLAVID is a trademark filed by Calla Lily Clinical Care Ltd on February 9, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Calla Lily Clinical Care Ltd

86-90 Paul Street,

Entity Type: 99

Trademark Details

Filing Date

February 9, 2024

Registration Date

January 20, 2026

Published for Opposition

December 2, 2025

Goods & Services

Pharmaceutical and medical preparations for use in the area of the vagina; sanitary preparations for medical purposes; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceutical preparations including probiotics for medicinal use; drug delivery agents being compounds for use in the vagina that facilitate the delivery of pharmaceutical preparations including probiotics for medicinal use; absorbent sanitary articles being sanitary pads, tampons or a combination of the two; novel cancer therapies, namely, pharmaceutical preparations and substances for the treatment of cancer; moisturisers, gels, creams and pessaries for use within and in the area of the vagina, all for medical purposes

Medical apparatus and instruments for use in gynecological medicine; intra-vaginal apparatus for administering lubricants, moisturisers, gels, creams and vaginal suppositories; intra-vaginal pessaries being vaginal drug delivery devices for administering medications and therapeutics; intra-vaginal pessaries being vaginal drug delivery devices for use in pregnancy loss and prevention; intra-vaginal pessaries being vaginal drug delivery devices for use in IVF; intra-vaginal pessaries being vaginal drug delivery devices for use in menopause; intra-vaginal pessaries being vaginal drug delivery devices for the treatment of cancer; intra-vaginal pessaries being vaginal delivery devices for use in delivering probiotic preparations; intra-vaginal pessaries being vaginal drug delivery devices for use in treating vaginal symptoms; intra-vaginal pessaries being vaginal delivery devices for use in delivering pharmaceutical preparations for use in artificial insemination; intra-vaginal pessaries being vaginal drug delivery devices for administering drugs internally; replacement parts and structural fittings for all the aforesaid goods

Filing History

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 20, 2026 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 22, 2026 OPNX
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 20, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 20, 2026 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 7, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 7, 2026 OPNR
NOTIFICATION PROCESSED BY IB
Dec 18, 2025 GPNX
CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 18, 2025 ADCH
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 2, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 2, 2025 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 26, 2025 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 26, 2025 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 25, 2025 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 5, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 13, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 13, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 13, 2025 ERFR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 22, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 22, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 22, 2025 REAP
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 16, 2025 GNFN
FINAL REFUSAL E-MAILED
Apr 16, 2025 GNFR
FINAL REFUSAL WRITTEN
Apr 16, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 13, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 13, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 13, 2025 TROA
REFUSAL PROCESSED BY IB
Oct 8, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 13, 2024 RFCS
REFUSAL PROCESSED BY MPU
Sep 13, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 11, 2024 RFCR
NON-FINAL ACTION WRITTEN
Sep 10, 2024 CNRT
ASSIGNED TO EXAMINER
Sep 3, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 19, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 19, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 8, 2024 REPR